Ryan Sullivan
Long/short equity, biotech, growth, long-term horizon

Argos Therapeutics: No Light At The End Of The Tunnel

Argos Therapeutics (NASDAQ:ARGS) recently completed its IPO, raising $45 million in an offering at $8/share. This is far below the estimated range of $13-15 for which the company had initially hoped. The stock opened for trading on 02/07/14 at $8.90, and quickly dropped to the offering price of $8/share, with 19,048,958 shares outstanding, for a total market capitalization of $152m.

This company initially filed for an IPO in early 2012, then subsequently withdrew its application, citing market conditions. It would appear that the market was not any kinder to them this time around. Here, I detail my investment thesis on ARGS. As positive as I am on the technology, I would recommend avoiding this stock, as the cash...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details